Page last updated: 2024-10-30

leflunomide and Drug Hypersensitivity

leflunomide has been researched along with Drug Hypersensitivity in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vesel, T1
Luzar, B1
Calonje, E1
Avcin, T1
Suzuki, Y1
Saito, E1
Wakabayashi, T1
Suwa, A1

Reviews

1 review available for leflunomide and Drug Hypersensitivity

ArticleYear
[Adverse effects of conventional DMARDs and biologic DMARDs].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug

2007

Other Studies

1 other study available for leflunomide and Drug Hypersensitivity

ArticleYear
Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
    Journal of cutaneous pathology, 2009, Volume: 36, Issue:9

    Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Hypersensit

2009